MENU
+Compare
RPRX
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$24.47
Change
-$0.65 (-2.59%)
Capitalization
11.16B

RPRX Royalty Pharma plc Forecast, Technical & Fundamental Analysis

a provider of drug development services

Industry Biotechnology
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for RPRX with price predictions
Dec 17, 2024

RPRX's RSI Indicator recovers from oversold territory

The RSI Oscillator for RPRX moved out of oversold territory on December 16, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 29 similar instances when the indicator left oversold territory. In of the 29 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RPRX advanced for three days, in of 238 cases, the price rose further within the following month. The odds of a continued upward trend are .

RPRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 06, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on RPRX as a result. In of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RPRX turned negative on December 10, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RPRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RPRX entered a downward trend on November 19, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.583) is normal, around the industry mean (14.664). P/E Ratio (9.634) is within average values for comparable stocks, (87.689). RPRX's Projected Growth (PEG Ratio) (5.310) is slightly higher than the industry average of (1.783). RPRX's Dividend Yield (0.034) is considerably higher than the industry average of (0.012). P/S Ratio (6.439) is also within normal values, averaging (260.687).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RPRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RPRX is expected to report earnings to rise 13.36% to $1.04 per share on February 12

Royalty Pharma plc RPRX Stock Earnings Reports
Q4'24
Est.
$1.04
Q3'24
Missed
by $0.01
Q2'24
Est.
$0.97
Q1'24
Missed
by $0.01
Q4'23
Beat
by $0.14
The last earnings report on November 06 showed earnings per share of 91 cents, missing the estimate of 92 cents. With 3.73M shares outstanding, the current market capitalization sits at 11.16B.
A.I.Advisor
published Dividends

RPRX paid dividends on December 10, 2024

Royalty Pharma plc RPRX Stock Dividends
А dividend of $0.21 per share was paid with a record date of December 10, 2024, and an ex-dividend date of November 15, 2024. Read more...
A.I. Advisor
published General Information

General Information

a provider of drug development services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
110 East 59th Street
Phone
+1 212 883-0200
Employees
89
Web
https://www.royaltypharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GNMA43.37N/A
N/A
iShares GNMA Bond ETF
FBOT28.70-0.02
-0.06%
Fidelity Disruptive Automation ETF
DWMF27.30-0.05
-0.20%
WisdomTree International Mltfctr
FDLO62.19-0.16
-0.26%
Fidelity Low Volatility Factor ETF
VUG426.93-1.18
-0.28%
Vanguard Growth ETF

RPRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RPRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RPRX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPRX
1D Price
Change %
RPRX100%
+0.48%
AXON - RPRX
48%
Loosely correlated
-2.09%
ADAP - RPRX
33%
Loosely correlated
+1.35%
MDGL - RPRX
31%
Poorly correlated
-1.58%
ARRY - RPRX
30%
Poorly correlated
+6.01%
QURE - RPRX
29%
Poorly correlated
-5.40%
More